EUVIMEDEUVIMED entdecken
ValidierungsstudieOpen Access

Different approaches of SARC‐tools for Sarcopenia Screening in chronic obstructive pulmonary disease: A cross‐sectional validation study

Alicia S Hartmann iD, João G Brum iD, Thiago G Barbosa-Silva iD, M Cristina Gonzalez iD, Juliessa Florian, Flávia M Silva iD

Journal of Parenteral and Enteral Nutrition · 2026-07 · 50 (5) · 717-726

DOI: 10.1002/jpen.70099 ↗

Kurz gefasst

Validierungsstudie in der Zeitschrift Journal of Parenteral and Enteral Nutrition, online erschienen am 07.05.2026. Verfasst von Alicia S Hartmann und 5 weiteren Autor:innen. Beteiligte Einrichtung: Federal University of Health Sciences of Porto Alegre, Porto Alegre, Rio Grande do Sul, Brazil. Hauptthemen laut MEDLINE: Pulmonary Disease, Chronic Obstructive, Sarcopenia, Mass Screening. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

We aimed to assess the concurrent and predictive validity of different screening tools for sarcopenia in outpatients with chronic obstructive pulmonary disease.

Methods

Cross‐sectional study with 124 community‐dwelling adults with chronic obstructive pulmonary disease (67.8 ± 8.4 years, 57.6% female). SARC‐F, SARC‐CalF, and SARC‐CalF BMI‐CC were applied; sarcopenia was diagnosed and considered as reference to test the concurrent validity. The outcomes evaluated to test the predictive validity included dyspnea severity, stage of disease, quality of life, the 6‐min walk test, and the prognosis index.

Results

SARC‐CalF BMI‐CC presented the highest sensitivity (79.5% vs 43.2% vs 20.5%), and negative predictive value (78.6% vs 68.8% vs 66.3%) compared to SARC‐CalF and SARC‐F, respectively. Patients with sarcopenia risk by SARC‐CalF BMI‐CC were 3.37 times (95% CI 1.18; 9.63) more likely to walk less than 350 m, 5.31 times (95% CI 2.01; 14.04) more likely to have poorer prognosis, 4.05 times (95% CI 1.55; 10.61) more likely to experience greater shortness of breath, and 6.4 times (95% CI 1.94; 21.13) more likely to have diminished quality of life. Risk of sarcopenia identified by SARC‐F (advanced stage of disease, poor prognosis and quality of life) and SARC‐Calf (advanced stage of disease, poor prognosis, and reduced functional capacity) was associated with a lower number of outcomes.

Conclusions

SARC‐CalF BMI‐CC demonstrated the highest accuracy to identify sarcopenia. Patients with sarcopenia risk by SARC‐CalF BMI‐CC were more likely to present worse outcomes compared to those identified by SARC‐F or SARC‐Calf, suggesting the use of SARC‐CalF BMI‐CC for these patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pulmonary Disease, Chronic ObstructiveSarcopeniaMass ScreeningHumansFemaleCross-Sectional StudiesAgedMaleQuality of LifeMiddle AgedWalk TestSeverity of Illness IndexPrognosisDyspneaPredictive Value of TestsReproducibility of ResultsSensitivity and Specificity

Stichwörter der Autor:innen

chronic obstructivedata accuracyprognosispulmonary diseasesarcopenia

Autor:innen und Institutionen

  • Federal University of Health Sciences of Porto Alegre, Porto Alegre, Rio Grande do Sul, Brazil.
  • Department of General Surgery, Faculty of Medicine, Federal University of Pelotas, Pelotas, Rio Grande do Sul, Brazil.
  • Postgraduate Program in Nutrition and Food, Federal University of Pelotas, Pelotas, Rio Grande do Sul, Brazil.
  • Pavilhão Pereira Filho, Santa Casa Hospital Complex, Porto Alegre, Rio Grande do Sul, Brazil.
  • Nutrition Department and Nutrition Sciences Graduate Program of Federal University of Health Sciences of Porto Alegre, Porto Alegre, Rio Grande do Sul, Brazil.

ORCID-Profile: Alicia S Hartmann, João G Brum, Thiago G Barbosa-Silva, M Cristina Gonzalez, Flávia M Silva

Zitieren

APA

Hartmann, A. S., Brum, J. G., Barbosa-Silva, T. G., Gonzalez, M. C., Florian, J., & Silva, F. M. (2026). Different approaches of SARC‐tools for Sarcopenia Screening in chronic obstructive pulmonary disease: A cross‐sectional validation study. Journal of Parenteral and Enteral Nutrition, 50(5), 717-726. https://doi.org/10.1002/jpen.70099

Vancouver

Hartmann AS, Brum JG, Barbosa-Silva TG, Gonzalez MC, Florian J, Silva FM. Different approaches of SARC‐tools for Sarcopenia Screening in chronic obstructive pulmonary disease: A cross‐sectional validation study. Journal of Parenteral and Enteral Nutrition. 2026;50(5):717-726. doi:10.1002/jpen.70099

BibTeX
@article{Hartmann2026,
  author = {Hartmann, Alicia S and Brum, João G and Barbosa-Silva, Thiago G and Gonzalez, M Cristina and Florian, Juliessa and Silva, Flávia M},
  title = {Different approaches of SARC‐tools for Sarcopenia Screening in chronic obstructive pulmonary disease: A cross‐sectional validation study},
  journal = {Journal of Parenteral and Enteral Nutrition},
  year = {2026},
  volume = {50},
  number = {5},
  pages = {717--726},
  doi = {10.1002/jpen.70099}
}
Kostenlos starten →